{"id":"https://openalex.org/W4211246979","doi":"https://doi.org/10.1111/cts.13235","title":"Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet\u2010induced obese and biopsy\u2010confirmed mouse model of NASH","display_name":"Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet\u2010induced obese and biopsy\u2010confirmed mouse model of NASH","alternate_titles":[],"publication_year":2022,"publication_date":"2022-02-24","ids":{"openalex":"https://openalex.org/W4211246979","doi":"https://doi.org/10.1111/cts.13235","pmid":"https://pubmed.ncbi.nlm.nih.gov/35143711","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9099137"},"language":"en","primary_location":{"id":"doi:10.1111/cts.13235","doi":"https://doi.org/10.1111/cts.13235","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13235","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13235","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4211246979"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13235","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031025187","display_name":"Mathias Bonde M\u00f8llerh\u00f8j","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mathias B. M\u00f8llerh\u00f8j","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110889969","display_name":"Sanne Skovg\u00e5rd Veidal","orcid":"https://orcid.org/0000-0003-1240-2034","observed_orcids":["https://orcid.org/0000-0003-1240-2034"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sanne S. Veidal","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066580974","display_name":"K.S. T\u00f8lb\u00f8l","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kirstine T\u00f8lb\u00f8l Thrane","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052984593","display_name":"Denise Or\u00f3","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Denise Or\u00f3","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047405265","display_name":"Agnete Overgaard","orcid":"https://orcid.org/0009-0006-6559-8391","observed_orcids":["https://orcid.org/0009-0006-6559-8391","https://orcid.org/0000-0003-2058-9986"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Agnete Overgaard","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103980615","display_name":"Casper Gravesen Salinas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Casper Gravesen Salinas","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103237065","display_name":"Martin R\u00f8nn Madsen","orcid":"https://orcid.org/0009-0003-1847-2188","observed_orcids":["https://orcid.org/0009-0003-1847-2188"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin R\u00f8nn Madsen","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004560260","display_name":"Larissa Pfisterer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Larissa Pfisterer","raw_affiliation_strings":["Boehringer\u2010Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer\u2010Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049482844","display_name":"Mogens Vyberg","orcid":"https://orcid.org/0000-0002-6392-9517","observed_orcids":["https://orcid.org/0000-0002-6392-9517"]},"institutions":[{"id":"https://openalex.org/I891191580","display_name":"Aalborg University","ror":"https://ror.org/04m5j1k67","country_code":"DK","type":"education","lineage":["https://openalex.org/I891191580"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mogens Vyberg","raw_affiliation_strings":["Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for RNA Medicine, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark","institution_ids":["https://openalex.org/I891191580"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eric Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Simon","raw_affiliation_strings":["Boehringer\u2010Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer\u2010Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062070235","display_name":"Andre Broermann","orcid":"https://orcid.org/0000-0002-4768-9074","observed_orcids":["https://orcid.org/0000-0002-4768-9074"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andre Broermann","raw_affiliation_strings":["Boehringer\u2010Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer\u2010Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088582143","display_name":"Niels Vrang","orcid":"https://orcid.org/0000-0002-7203-9532","observed_orcids":["https://orcid.org/0000-0002-7203-9532"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Niels Vrang","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075602116","display_name":"Jacob Jelsing","orcid":"https://orcid.org/0000-0002-4583-1022","observed_orcids":["https://orcid.org/0000-0002-4583-1022"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacob Jelsing","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067265775","display_name":"Michael Feigh","orcid":"https://orcid.org/0000-0001-5274-8799","observed_orcids":["https://orcid.org/0000-0001-5274-8799"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Feigh","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001683046","display_name":"Henrik H. Hansen","orcid":"https://orcid.org/0000-0002-3732-0281","observed_orcids":["https://orcid.org/0000-0002-3732-0281"]},"institutions":[{"id":"https://openalex.org/I4210113742","display_name":"Gubra (Denmark)","ror":"https://ror.org/0244cxh34","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210113742"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Henrik H. Hansen","raw_affiliation_strings":["Gubra  H\u00f8rsholm Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gubra  H\u00f8rsholm Denmark","institution_ids":["https://openalex.org/I4210113742"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5001683046"],"corresponding_institution_ids":["https://openalex.org/I4210113742"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":7.2572,"has_fulltext":true,"cited_by_count":88,"citation_normalized_percentile":{"value":0.98351434,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"15","issue":"5","first_page":"1167","last_page":"1186"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/nash-mouse-model","display_name":"NASH mouse model","score":0.6980000138282776},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.9660000205039978},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9399999976158142},{"id":"https://openalex.org/keywords/lanifibranor","display_name":"lanifibranor","score":1.0},{"id":"https://openalex.org/keywords/dietary-intervention","display_name":"dietary intervention","score":0.9010000228881836},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.7839999794960022},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9049999713897705},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.824999988079071},{"id":"https://openalex.org/keywords/nafld-activity-score","display_name":"NAFLD activity score","score":0.8379999995231628},{"id":"https://openalex.org/keywords/deep-learning-image-analysis","display_name":"deep learning image analysis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7128791213035583},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.5908029675483704},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.5600132346153259},{"id":"https://openalex.org/C2777766500","wikidata":"https://www.wikidata.org/wiki/Q360841","display_name":"Liver biopsy","level":3,"score":0.5339322090148926},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5121262073516846},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.5102851390838623},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.4939728379249573},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.38011741638183594},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3467756509780884},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3355628252029419},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.3300320506095886},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29329103231430054},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.27996939420700073},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.1239742636680603}],"mesh":[{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001706","descriptor_name":"Biopsy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004032","descriptor_name":"Diet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008820","descriptor_name":"Mice, Obese","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D065626","descriptor_name":"Non-alcoholic Fatty Liver Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/cts.13235","doi":"https://doi.org/10.1111/cts.13235","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13235","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13235","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},{"id":"pmh:oai:pure.atira.dk:openaire/320c8fd9-d6c4-480b-89eb-ea6ace33de41","doi":null,"is_oa":true,"landing_page_url":"https://vbn.aau.dk/da/publications/320c8fd9-d6c4-480b-89eb-ea6ace33de41","pdf_url":"https://vbn.aau.dk/ws/files/475851109/M_llerh_j_et_al._2022_._Hepatoprotective_effects_of_semaglutide_lanifibranor_and_dietary_intervention_in_the_GAN_diet_induced_obese_and_biopsy_confirmed_mouse_model_of_NASH.pdf","source":{"id":"https://openalex.org/S4306401731","display_name":"VBN Forskningsportal (Aalborg Universitet)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I891191580","host_organization_name":"Aalborg University","host_organization_lineage":["https://openalex.org/I891191580"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"M\u00f8llerh\u00f8j, M B, Veidal, S S, Thrane, K T, Or\u00f3, D, Overgaard, A, Salinas, C G, Madsen, M R, Pfisterer, L, Vyberg, M, Simon, E, Broermann, A, Vrang, N, Jelsing, J, Feigh, M & Hansen, H H 2022, 'Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH', Clinical and translational science, vol. 15, no. 5, pp. 1167-1186. https://doi.org/10.1111/cts.13235","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9099137","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9099137/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Transl Sci","raw_type":"Text"},{"id":"pmid:35143711","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35143711","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and translational science","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:5fe3d3005960450b826f54e82c75529a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5fe3d3005960450b826f54e82c75529a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Translational Science, Vol 15, Iss 5, Pp 1167-1186 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1111/cts.13235","doi":"https://doi.org/10.1111/cts.13235","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13235","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.13235","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G342286053","display_name":null,"funder_award_id":"#NNF17SA0031406","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"},{"id":"https://openalex.org/G4343097196","display_name":null,"funder_award_id":"NNF17SA0031406]","funder_id":"https://openalex.org/F4320315655","funder_display_name":"Danish Diabetes Academy"},{"id":"https://openalex.org/G4554591249","display_name":null,"funder_award_id":"9065-00252","funder_id":"https://openalex.org/F4320313796","funder_display_name":"Innovationsfonden"},{"id":"https://openalex.org/G4967664143","display_name":null,"funder_award_id":"NNF18OC0033438","funder_id":"https://openalex.org/F4320325957","funder_display_name":"Novo Nordisk Fonden"},{"id":"https://openalex.org/G5476537510","display_name":null,"funder_award_id":"NNF17SA0031406","funder_id":"https://openalex.org/F4320322436","funder_display_name":"Novo Nordisk"}],"funders":[{"id":"https://openalex.org/F4320313796","display_name":"Innovationsfonden","ror":"https://ror.org/00daj4111"},{"id":"https://openalex.org/F4320315655","display_name":"Danish Diabetes Academy","ror":"https://ror.org/05xbkrn90"},{"id":"https://openalex.org/F4320321409","display_name":"Aalborg Universitet","ror":"https://ror.org/04m5j1k67"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320325957","display_name":"Novo Nordisk Fonden","ror":"https://ror.org/04txyc737"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4211246979.pdf","grobid_xml":"https://content.openalex.org/works/W4211246979.grobid-xml"},"referenced_works_count":64,"referenced_works":["https://openalex.org/W1970250630","https://openalex.org/W1979288606","https://openalex.org/W1990248309","https://openalex.org/W1992116679","https://openalex.org/W2017948134","https://openalex.org/W2023461955","https://openalex.org/W2033361774","https://openalex.org/W2041447975","https://openalex.org/W2065107673","https://openalex.org/W2067740038","https://openalex.org/W2113653640","https://openalex.org/W2132715587","https://openalex.org/W2139318977","https://openalex.org/W2161872363","https://openalex.org/W2161883681","https://openalex.org/W2163484250","https://openalex.org/W2182670456","https://openalex.org/W2215535790","https://openalex.org/W2469365710","https://openalex.org/W2507524244","https://openalex.org/W2519479884","https://openalex.org/W2613180696","https://openalex.org/W2730267177","https://openalex.org/W2774655822","https://openalex.org/W2783806692","https://openalex.org/W2787846545","https://openalex.org/W2789841804","https://openalex.org/W2800258246","https://openalex.org/W2810423511","https://openalex.org/W2899389750","https://openalex.org/W2899595328","https://openalex.org/W2901814223","https://openalex.org/W2901979245","https://openalex.org/W2911080438","https://openalex.org/W2924479779","https://openalex.org/W2927712631","https://openalex.org/W2929875152","https://openalex.org/W2941033601","https://openalex.org/W2953485865","https://openalex.org/W2971782246","https://openalex.org/W2984524859","https://openalex.org/W2994912142","https://openalex.org/W2997837979","https://openalex.org/W3006306205","https://openalex.org/W3013242926","https://openalex.org/W3022387787","https://openalex.org/W3022452643","https://openalex.org/W3025611952","https://openalex.org/W3034691659","https://openalex.org/W3039496711","https://openalex.org/W3084300541","https://openalex.org/W3102426258","https://openalex.org/W3109708108","https://openalex.org/W3119825458","https://openalex.org/W3133746780","https://openalex.org/W3138288621","https://openalex.org/W3138431202","https://openalex.org/W3160163020","https://openalex.org/W3162136356","https://openalex.org/W3163483026","https://openalex.org/W3173984559","https://openalex.org/W3193498370","https://openalex.org/W3207086349","https://openalex.org/W3208498374"],"related_works":["https://openalex.org/W4390339797","https://openalex.org/W4384941949","https://openalex.org/W2783806692","https://openalex.org/W2970272830","https://openalex.org/W2613630613","https://openalex.org/W3009966243","https://openalex.org/W3039496711","https://openalex.org/W4411571488","https://openalex.org/W2948448741","https://openalex.org/W3034607507"],"abstract_inverted_index":{"Non-alcoholic":[0],"steatohepatitis":[1],"(NASH)":[2],"has":[3],"emerged":[4],"as":[5],"a":[6],"major":[7],"challenge":[8],"for":[9,91,115,239],"public":[10],"health":[11],"because":[12],"of":[13,19,25,54,161,198,225,233,247],"high":[14,85,159],"global":[15],"prevalence":[16],"and":[17,33,52,63,89,100,117,132,148,155,170,192,201,211,227],"lack":[18,27],"evidence-based":[20],"therapies.":[21],"Most":[22],"animal":[23],"models":[24],"NASH":[26,38,99,226],"sufficient":[28],"validation":[29],"regarding":[30],"disease":[31,50,61,127],"progression":[32,62,150],"pharmacological":[34],"treatment.":[35],"The":[36],"Gubra-Amylin":[37],"(GAN)":[39],"diet-induced":[40],"obese":[41],"(DIO)":[42],"mouse":[43,219],"demonstrate":[44],"clinical":[45,166,237],"translatability":[46],"with":[47,97,158,165],"respect":[48],"to":[49,59,65],"etiology":[51],"hallmarks":[53],"NASH.":[55,240],"This":[56],"study":[57],"aimed":[58],"evaluate":[60],"responsiveness":[64],"clinically":[66],"effective":[67],"interventions":[68],"in":[69,77,86,123,151,179,235,251],"GAN":[70,83,94,143,217,248],"DIO-NASH":[71,95,144,218,249],"mice.":[72],"Disease":[73],"phenotyping":[74],"was":[75,135,204],"performed":[76],"male":[78],"C57BL/6J":[79],"mice":[80,96,145,250],"fed":[81],"the":[82,180,216,245],"diet":[84],"fat,":[87],"fructose,":[88],"cholesterol":[90],"28-88":[92],"weeks.":[93],"biopsy-confirmed":[98],"fibrosis":[101,133,153,181],"received":[102],"low-caloric":[103],"dietary":[104,202],"intervention,":[105],"semaglutide":[106,169],"(30":[107,112],"nmol/kg/day,":[108],"s.c.)":[109],"or":[110],"lanifibranor":[111,171,176],"mg/kg/day,":[113],"p.o.)":[114],"8":[116],"12":[118],"weeks,":[119],"respectively.":[120],"Within-subject":[121],"change":[122],"nonalcoholic":[124],"fatty":[125],"liver":[126,193],"(NAFLD)":[128],"Activity":[129],"Score":[130],"(NAS)":[131],"stage":[134],"evaluated":[136],"using":[137],"automated":[138],"deep":[139],"learning-based":[140],"image":[141],"analysis.":[142],"showed":[146],"clear":[147],"reproducible":[149],"NASH,":[152],"stage,":[154],"tumor":[156],"burden":[157],"incidence":[160],"hepatocellular":[162],"carcinoma.":[163],"Consistent":[164],"trial":[167],"outcomes,":[168],"improved":[172],"NAS,":[173],"whereas":[174],"only":[175],"induced":[177],"regression":[178],"stage.":[182],"Dietary":[183],"intervention":[184,203],"also":[185],"demonstrated":[186],"substantial":[187],"benefits":[188],"on":[189],"metabolic":[190],"outcomes":[191],"histology.":[194],"Differential":[195],"therapeutic":[196],"efficacy":[197,231],"semaglutide,":[199],"lanifibranor,":[200],"supported":[205],"by":[206],"quantitative":[207],"histology,":[208],"RNA":[209],"sequencing,":[210],"blood/liver":[212],"biochemistry.":[213],"In":[214],"conclusion,":[215],"model":[220],"recapitulates":[221],"various":[222],"histological":[223,230],"stages":[224],"faithfully":[228],"reproduces":[229],"profiles":[232],"compounds":[234],"advanced":[236],"development":[238],"Collectively,":[241],"these":[242],"features":[243],"highlight":[244],"utility":[246],"preclinical":[252],"drug":[253],"development.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4211246979","counts_by_year":[{"year":2026,"cited_by_count":27},{"year":2025,"cited_by_count":20},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-02-13T00:00:00"}
